• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentation.

作者信息

Mahajan Arjun, Chen Ryan, Fischer Grant M, Xiong Yuqing, Ashrafzadeh Sepideh, Said Jordan T, Nambudiri Vinod E

机构信息

Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

Harvard Medical School, Boston, Massachusetts.

出版信息

JAAD Case Rep. 2024 Oct 28;54:69-72. doi: 10.1016/j.jdcr.2024.10.004. eCollection 2024 Dec.

DOI:10.1016/j.jdcr.2024.10.004
PMID:39654850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11626045/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6f/11626045/86b05f938d71/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6f/11626045/110be6b3082e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6f/11626045/86b05f938d71/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6f/11626045/110be6b3082e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6f/11626045/86b05f938d71/gr2.jpg

相似文献

1
Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentation.帕博利珠单抗诱发的史蒂文斯-约翰逊综合征样反应：一种非典型临床表现。
JAAD Case Rep. 2024 Oct 28;54:69-72. doi: 10.1016/j.jdcr.2024.10.004. eCollection 2024 Dec.
2
Pembrolizumab-induced Stevens-Johnson Syndrome with Severe Ocular Complications.帕博利珠单抗引起的史蒂文斯-约翰逊综合征伴严重眼部并发症。
Ocul Immunol Inflamm. 2022 Aug;30(6):1533-1535. doi: 10.1080/09273948.2021.1896006. Epub 2021 Apr 7.
3
Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer.一名越南非小细胞肺癌患者发生帕博利珠单抗诱导的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
Asia Pac Allergy. 2024 Jun;14(2):84-89. doi: 10.5415/apallergy.0000000000000131. Epub 2023 Dec 18.
4
Atypical Presentation of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in a Patient on Pembrolizumab: A Case Report.帕博利珠单抗治疗患者出现药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）的非典型表现：一例报告
Cureus. 2024 May 7;16(5):e59804. doi: 10.7759/cureus.59804. eCollection 2024 May.
5
Clinical features, treatment, and prognosis of pembrolizumab -induced Stevens-Johnson syndrome / toxic epidermal necrolysis.帕博利珠单抗诱导的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的临床特征、治疗及预后
Invest New Drugs. 2025 Feb;43(1):74-80. doi: 10.1007/s10637-024-01499-z. Epub 2025 Jan 3.
6
Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.史蒂文斯-约翰逊综合征在帕博利珠单抗治疗过程后期出现。
J Oncol Pharm Pract. 2019 Sep;25(6):1520-1522. doi: 10.1177/1078155218791314. Epub 2018 Aug 7.
7
Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.帕博利珠单抗诱发的转移性食管腺癌患者中毒性表皮坏死松解症
R I Med J (2013). 2022 Apr 1;105(3):34-36.
8
Stevens-Johnson syndrome and toxic epidermal necrolysis-like eruptions in patients treated with immune checkpoint inhibitors: a systematic review.免疫检查点抑制剂治疗患者的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症样皮疹：系统评价。
Int J Dermatol. 2024 Dec;63(12):e397-e404. doi: 10.1111/ijd.17479. Epub 2024 Sep 16.
9
Pembrolizumab associated Stevens-Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma.帕博利珠单抗相关史蒂文斯-约翰逊综合征伴原发性肝细胞癌患者的角化不良。
Australas J Dermatol. 2022 Feb;63(1):e71-e74. doi: 10.1111/ajd.13704. Epub 2021 Aug 31.
10
Stevens-Johnson Syndrome-Like Reaction After Exposure to Pembrolizumab and Recombinant Zoster Vaccine in a Patient With Metastatic Lung Cancer.患者患有转移性肺癌，在接受派姆单抗和重组带状疱疹疫苗治疗后出现史蒂文斯-约翰逊综合征样反应。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620914796. doi: 10.1177/2324709620914796.

本文引用的文献

1
Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.免疫检查点抑制剂诱导的表皮坏死松解症：评估人口统计学、临床特征和罪魁祸首药物的叙述性综述。
J Dermatol. 2024 Jan;51(1):3-11. doi: 10.1111/1346-8138.17039. Epub 2023 Nov 30.
2
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.免疫治疗相关毒性管理，版本 1.2022，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Apr;20(4):387-405. doi: 10.6004/jnccn.2022.0020.
3
Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.
帕博利珠单抗诱发的转移性食管腺癌患者中毒性表皮坏死松解症
R I Med J (2013). 2022 Apr 1;105(3):34-36.
4
Generalized bullous mucocutaneous eruption mimicking Stevens-Johnson syndrome in the setting of immune checkpoint inhibition: A multicenter case series.免疫检查点抑制背景下酷似史蒂文斯-约翰逊综合征的泛发性大疱性黏膜皮肤疹：一项多中心病例系列研究
J Am Acad Dermatol. 2020 Nov;83(5):1475-1477. doi: 10.1016/j.jaad.2020.03.029. Epub 2020 Mar 19.
5
The life-threatening eruptions of immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗的危及生命的爆发。
Clin Dermatol. 2020 Jan-Feb;38(1):94-104. doi: 10.1016/j.clindermatol.2019.10.015. Epub 2019 Oct 25.
6
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症：美国 377 例成年患者的多中心回顾性研究。
J Invest Dermatol. 2018 Nov;138(11):2315-2321. doi: 10.1016/j.jid.2018.04.027. Epub 2018 Jul 27.
7
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症：一篇简要综述，全面总结治疗干预措施，重点强调支持性措施
Adv Ther. 2017 Jun;34(6):1235-1244. doi: 10.1007/s12325-017-0530-y. Epub 2017 Apr 24.
8
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.抗程序性死亡蛋白1（PD-1）和抗程序性死亡配体1（PD-L1）免疫检查点抗体的毒性。
Ann Oncol. 2015 Dec;26(12):2375-91. doi: 10.1093/annonc/mdv383. Epub 2015 Sep 14.
9
ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.ALDEN 算法用于评估 Stevens-Johnson 综合征和中毒性表皮坏死松解症中的药物相关性：与病例对照分析的比较。
Clin Pharmacol Ther. 2010 Jul;88(1):60-8. doi: 10.1038/clpt.2009.252. Epub 2010 Apr 7.
10
SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.SCORTEN：一种中毒性表皮坏死松解症的疾病严重程度评分系统。
J Invest Dermatol. 2000 Aug;115(2):149-53. doi: 10.1046/j.1523-1747.2000.00061.x.